ST复华 (600624)

Shanghai Fudan Forward Science and Technology Co., Ltd.

ASH

Tags

New QFII HoldingsSpecial Treatment (ST) SectorBrain-Computer InterfaceGeneric DrugsVenture Capital ConceptChemical PharmaceuticalsPharmaceutical ManufacturingPharmaceuticals and HealthcareDomestic SoftwareProperty ManagementHepatitis ConceptQuantum Technology

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 67934.69
  • Circulating A-Shares(W): 67934.69
  • Earnings Per Share(RMB): -0.0265
  • Net Assets Per Share(RMB): 0.9158
  • Operating Revenue(W RMB): 49272.00
  • Total Profit(W RMB): -1467.26
  • **Net Profit Attributable to Parent(W RMB) **: -1801.65
  • Net Profit Growth Rate(%): 44.06
  • Weighted Return on Equity(%): -2.8700
  • Operating Cash Flow Per Share(RMB): -0.0320
  • Undistributed Profit Per Share(RMB): -0.2634
  • Capital Reserve Per Share(RMB): 0.2095

2. Main Business

The main business covers:

  • Pharmaceutical Industry
  • Software
  • Park Industry

3. Company Basic Information

  • Company Name: Shanghai Fudan Forward S&T Co., Ltd.
  • Listing Date: 1993-01-05
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 525 Guoquan Road, Shanghai
  • Website: https://www.forwardgroup.com/
  • Company Profile: The company's predecessor was Fudan University Science and Technology Development General Company. In July 1992, it began restructuring into a joint-stock company. The company converted the original company's net assets into state shares of 431,600 yuan with a face value of 10 yuan, and initiator corporate shares of 2,407,490 shares. After the initial public offering in June of the same year, the total number of shares reached 4,339,090 shares. When listed, the shares were split into 43,390,900 shares, with a face value of 1.00 yuan per share.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Shanghai Fengxian Investment (Group) Co., Ltd. Corporate Entity 12833.86 18.89
2 Shanghai Shangke Technology Investment Co., Ltd. Corporate Entity 6920.65 10.19
3 UBS AG QFII 200.68 0.30
4
5
6
7
8
9
10

5. Concept Sectors

  • ST Sector
  • Venture Capital Concept
  • Domestic Software
  • Quantum Technology
  • Generic Drugs
  • Brain-Computer Interface
  • Property Management
  • Hepatitis Concept
  • Yesterday Limit-Up
  • QFII New Entry
  • Yesterday ST Continuous Limit-Up

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information